The short answer
Methionine oxidises readily to the sulfoxide, which is normally described as degradation. Uniquely among common oxidative modifications it is enzymatically reversible, so methionine can absorb oxidative insult repeatedly, functioning as a regenerable buffer rather than simply being damaged.
Key facts
- Oxidation product
- Methionine sulfoxide, +16 Da
- Unusual property
- Enzymatically reversible
- Reducing enzymes
- Methionine sulfoxide reductases
- Consequence
- Repeatable, not one-way
- Proposed role
- Antioxidant buffer
- Key paper
- Bender 2008, PNAS (PMID 18946048)
Why most oxidative damage is permanent
Oxidation of most amino acid side chains produces products the cell cannot undo. Carbonylation of lysine or arginine, oxidation of tryptophan and cleavage of the peptide backbone are terminal, and the only remedy is degrading the protein and building another. Damage of that kind accumulates.
Why methionine is different
Its thioether sulfur oxidises to the sulfoxide, and cells possess methionine sulfoxide reductases that reduce it back. That makes the modification a cycle rather than an endpoint. A methionine residue can be oxidised, restored and oxidised again, which is a very different relationship with reactive oxygen than any residue that is simply destroyed.
Research material referenced
MOTS-C 10mg, third-party HPLC tested
How that becomes a defence
If methionine is preferentially oxidised, it intercepts oxidants that would otherwise reach residues where damage is permanent. Surface methionines effectively act as a sacrificial layer, and because the reductases restore them, the protective capacity regenerates rather than depleting. The residue is doing work by being vulnerable.
The argument Bender and colleagues made
That mitochondria increased methionine content deliberately, through the genetic code itself. Their 2008 PNAS paper argues adaptive antioxidant methionine accumulation in respiratory chain complexes explains why mitochondria use a deviant code. The AUA reassignment substitutes methionine for isoleucine, and the compartment doing so is the one producing the most reactive oxygen.
What this changes about reading a certificate
Nothing about handling: a +16 Da satellite still indicates oxidation, and oxidised material still differs from what was specified. But it reframes why a mitochondrial peptide is methionine-rich in the first place. The residues that make MOTS-c awkward to store are plausibly there for a reason, and vulnerability in a vial is not the same as vulnerability in a cell, because a cell has reductases and a vial does not.
Where the analogy stops
Regeneration requires enzymes. A lyophilised peptide in a vial has none, so oxidation there is one-way and cumulative in just the way the storage guidance assumes. The functional argument concerns methionine inside a living system; the handling concern concerns methionine in storage. Both are correct and they describe different situations.
Frequently asked questions
Is methionine oxidation reversible?
In cells, yes. Methionine sulfoxide reductases reduce it back, which is unusual among oxidative modifications.
How does that make it an antioxidant?
Preferential oxidation intercepts oxidants that would otherwise damage residues permanently, and the reductases regenerate the capacity.
Does this change storage advice?
No. A vial has no reductases, so oxidation there is one-way and cumulative. The functional role applies inside a living system.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
- PubMedBender A et al., Adaptive antioxidant methionine accumulation in respiratory chain complexes. PNAS 2008 (PMID 18946048)pubmed.ncbi.nlm.nih.gov
- PubMedStability of protein pharmaceuticals: an update. Pharm Res (PMID 20143256)pubmed.ncbi.nlm.nih.gov
- PubMedLee C et al. Cell Metab 2015 (PMID 25738459)pubmed.ncbi.nlm.nih.gov
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More MOTS-c (Mitochondrial Peptide) articles
- Two Methionines in Sixteen ResiduesMOTS-c is 12.5% methionine against roughly 2.3% across proteins generally - a five-fold enrichment, in a peptide from the genome whose code favours it.
- Why Mitochondrial Genetics Is Not Like Nuclear GeneticsCells carry many mitochondrial genomes, not two copies. Copy number and the mix of variants both vary, and both correlate with muscle oxidative capacity.
- A Class, Not a CompoundHumanin, MOTS-c and the SHLPs form a small family encoded within mitochondrial DNA. What reviews of the class establish, and what they concede.
- Why Exercise Keeps Appearing in This LiteratureContracting muscle releases signalling molecules that act on adipose tissue. Two 2025 papers place mitochondrial signalling inside that conversation.
- The Structural Reasons the Evidence Is ThinNo identified receptor, an unsettled site of translation, an indirect mechanism and a peptide that oxidises. Each is a real obstacle, not an excuse.